Steven R. Cummings
California Pacific Medical Center
Coordinating Center
Suite 600
74 New Montgomery Street
USA
Name/email consistency: high
- Sex hormones, risk factors, and risk of estrogen receptor-positive breast cancer in older women: a long-term prospective study. Cummings, S.R., Lee, J.S., Lui, L.Y., Stone, K., Ljung, B.M., Cauleys, J.A. Cancer Epidemiol. Biomarkers Prev. (2005)
- Issues in designing and testing a "cure" for osteoporosis. Cummings, S. J. Musculoskelet. Neuronal. Interact (2004)
- Summary--curing osteoporosis. Cummings, S. J. Musculoskelet. Neuronal. Interact (2004)
- Serum estradiol level and risk of breast cancer during treatment with raloxifene. Cummings, S.R., Duong, T., Kenyon, E., Cauley, J.A., Whitehead, M., Krueger, K.A. JAMA (2002)
- Epidemiology and outcomes of osteoporotic fractures. Cummings, S.R., Melton, L.J. Lancet (2002)
- Clinical use of bone densitometry: scientific review. Cummings, S.R., Bates, D., Black, D.M. JAMA (2002)
- How drugs decrease fracture risk: lessons from trials. Cummings, S.R. J. Musculoskelet. Neuronal. Interact (2002)
- The paradox of small changes in bone density and reductions in risk of fracture with raloxifene. Cummings, S.R. Ann. N. Y. Acad. Sci. (2001)
- The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. Cummings, S.R., Eckert, S., Krueger, K.A., Grady, D., Powles, T.J., Cauley, J.A., Norton, L., Nickelsen, T., Bjarnason, N.H., Morrow, M., Lippman, M.E., Black, D., Glusman, J.E., Costa, A., Jordan, V.C. JAMA (1999)
- Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. Cummings, S.R., Black, D.M., Thompson, D.E., Applegate, W.B., Barrett-Connor, E., Musliner, T.A., Palermo, L., Prineas, R., Rubin, S.M., Scott, J.C., Vogt, T., Wallace, R., Yates, A.J., LaCroix, A.Z. JAMA (1998)